A detailed history of Td Private Client Wealth LLC transactions in Halozyme Therapeutics, Inc. stock. As of the latest transaction made, Td Private Client Wealth LLC holds 38 shares of HALO stock, worth $1,862. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38
Previous 22 72.73%
Holding current value
$1,862
Previous $1.15 Million 88.8%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 18, 2024

BUY
$51.3 - $64.42 $820 - $1,030
16 Added 72.73%
38 $2.18 Million
Q2 2024

Aug 14, 2024

BUY
$37.81 - $52.4 $831 - $1,152
22 New
22 $1.15 Million
Q4 2021

Aug 16, 2024

SELL
$31.82 - $40.75 $763 - $978
-24 Closed
0 $0
Q3 2021

Aug 16, 2024

BUY
$38.47 - $46.42 $76 - $92
2 Added 9.09%
24 $976,000
Q4 2019

Aug 16, 2024

BUY
$14.93 - $19.53 $29 - $39
2 Added 9.09%
24 $426,000

Others Institutions Holding HALO

About HALOZYME THERAPEUTICS, INC.


  • Ticker HALO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 139,288,992
  • Market Cap $6.83B
  • Description
  • Halozyme Therapeutics, Inc. operates as a biopharma technology platform company in the United States, Switzerland, Ireland, Belgium, Japan, and internationally. The company's products are based on the ENHANZE drug delivery technology, a patented recombinant human hyaluronidase enzyme (rHuPH20) that enables the subcutaneous delivery of injectable...
More about HALO
Track This Portfolio

Track Td Private Client Wealth LLC Portfolio

Follow Td Private Client Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Private Client Wealth LLC with notifications on news.